医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Shionogi Inc. Enlists BuzzeoPDMA, a Cegedim Company to Support their Sample Management Compliance Programs

2014年09月05日 AM02:00
このエントリーをはてなブックマークに追加


 

BEDMINSTER, N.J.

BuzzeoPDMA, A Cegedim Company, today announced that Shionogi Inc. has selected BuzzeoPDMA’s sample management services to help the company maintain compliance with the FDA’s PDMA regulations. Shionogi Inc., the U.S.-based subsidiary of Shionogi & Co., Ltd., a leading Japanese pharmaceutical company, focuses in the therapeutic areas of pain, women’s health and cardiovascular disease.

Leveraging Proven and Comprehensive Compliance Expertise

BuzzeoPDMA will be providing sample accountability, annual inventories and other compliance services as required by U.S. compliance regulations. In addition to helping Shionogi continue to develop a comprehensive compliance plan around their sampling activities through best practices, activity reviews, and compliance forms, BuzzeoPDMA will perform on-site physical counts of all samples in Shionogi’s sales representatives’ possession. BuzzeoPDMA’s services for Shionogi will also include off-site prescription drug sample variance and reconciliation services utilizing BuzzeoPDMA’s Sample Guardian Software. BuzzeoPDMA’s proprietary web-based dashboard capability will be used to monitor all sample activity so that compliance and distribution teams can easily measure, monitor, and manage trends for all aspects of sampling programs.

“Working with one vendor who can provide a number of different Sample Accountability and field-based inventory services has been a real benefit, and helps us operate more effectively and efficiently. Their dashboard capability is going to make it easy for our compliance team to get the information they need when they need it,” said Brandy Conner, Director Sales Operations at Shionogi Inc. “We chose BuzzeoPDMA because of their strong track record in compliance.”

“We look forward to helping Shionogi improve their sample compliance processes to make them more efficient and increase operational effectiveness through our superior sample reconciliation support services,” said Paul Hamby, Senior Director of Compliance Solutions for BuzzeoPDMA. “In addition, our processes, experience and highly trained field inventory specialists will help their business be more proficient”.

BuzzeoPDMA combines 25 years of experience and an overall 99.5% customer satisfaction rating to deliver total management solutions that help pharmaceutical companies comply with DEA and FDA regulations cost effectively while maintaining operational efficiency. To learn more about our services, visit our website.

       

About
Cegedim
Relationship
Management:

   

Cegedim Relationship Management is the Life Sciences industry’s leading provider of Customer Relationship Management (CRM) solutions. Designed specifically for Life Sciences, the company’s innovative business solutions incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Relationship Management enables approximately 200,000 users in many of the world’s most innovative companies to stay ahead of market challenges. In addition to CRM, Cegedim Relationship Management also provides marketing, data optimization and regulatory compliance solutions in more than 80 countries. Cegedim Relationship Management is part of the France-based Cegedim S.A. Group.

 

To learn more, please visit: www.cegedim.com/rm.

Follow Cegedim Relationship Management on LinkedIn and Twitter.

 

About
Cegedim:

   

Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,000 people in more than 80 countries and generated revenue of €902 million in 2013. Cegedim SA is listed in Paris (EURONEXT: CGM).

 

To learn more, please visit: www.cegedim.com.

Follow Cegedim on Twitter: @CegedimGroup.

 

CONTACT

Drew BUSTOS
Cegedim Relationship Management
Global
Communications
Tel.: +1 (908) 443.2451
drew.bustos@cegedim.com
or
Aude
BALLEYDIER

Cegedim
Media Relations
Tel.: +33 (0)1 49
09 68 81
aude.balleydier@cegedim.fr

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Walmart, JD.com, IBM and Tsinghua University Launch a Blockchain Food Safety Alliance in China
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗